- Home
- AX vs GH Comparison
AX vs GH Comparison
Compare AX & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AX | GH |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 22.9B |
| IPO Year | 2004 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AX | GH |
|---|---|---|
| Price | $89.13 | $177.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 19 |
| Target Price | $103.14 | ★ $119.79 |
| AVG Volume (30 Days) | 268.6K | ★ 1.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.13 | 6.74 |
| EPS | ★ 8.48 | N/A |
| Revenue | $81,254,000.00 | ★ $982,021,000.00 |
| Revenue This Year | $24.76 | $33.30 |
| Revenue Next Year | $10.86 | $28.27 |
| P/E Ratio | $10.69 | ★ N/A |
| Revenue Growth | 23.51 | ★ 32.88 |
| 52 Week Low | $74.89 | $55.38 |
| 52 Week High | $105.74 | $183.51 |
Technical Indicators
Market Signals| Indicator | AX | GH |
|---|---|---|
| Relative Strength Index (RSI) | 38.15 | 53.82 |
| Support Level | $85.44 | $153.88 |
| Resistance Level | $92.05 | $173.94 |
| Average True Range (ATR) | 1.94 | 8.23 |
| MACD | -0.37 | 0.82 |
| Stochastic Oscillator | 18.92 | 56.78 |
Price Performance
Historical ComparisonAbout AX Axos Financial Inc.
Axos Financial Inc is a technology-driven, diversified financial services company. Its client-centric, technology-enabled services model provides secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. The Bank provides consumer and commercial banking products and services through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. It offers deposit and lending products to customers nationwide including consumer and business checking, savings, etc. Its segments are Banking Business Segment and the Securities Business Segment. Majority of income comes from Banking Business Segment- It distribute its loan products through its retail, correspondent and wholesale channels.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.